Th17 response and autophagy - Main pathways implicated in the development of inflammatory bowel disease by genome-wide association studies: New factors involved in inflammatory bowel disease susceptibility [Respuesta Th17 y autofagia: Principales vías implicadas en enfermedad inflamatoria intestinal por los estudios de asociación de genoma completo: Nuevos factores implicados en la susceptibilidad a enfermedad inflamatoria intestinal]
Inflammatory bowel disease (IBD) is an entity that mainly includes ulcerative colitis (UC) and Crohn’s disease (CD). Improved health care, diet changes, and higher industrialization are associated with an increase in IBD prevalence. This supports the central role of environmental factors in the pathology of this disease. However, IBD also shows a relevant genetic component as shown by high heritability. Classic genetic studies showed relevant associations between IBD susceptibility and genes involved in the immune response. This is consistent with prior theories about IBD development. According to these, contact of the immune system with a high number of harmless antigens from the diet and the bacterial flora should originate tolerance while preserving response against pathogens. Failure to achieve this balance may originate the typical inflammatory response associated with IBD. Recently, genome-wide association studies (GWASs) have confirmed the implication of the immune system, particularly the Th17 immune response, previously associated to other autoimmune diseases, and of autophagy. In this paper, the mechanisms involved in these two relevant pathways and their potential role in the pathogenesis of IBD are reviewed. © 2015 Arán Ediciones, S. L.
Showing items related by title, author, creator and subject.
ReviewAbdolmaleki F.; Farahani N.; Hayat S.M.G.; Pirro M.; Bianconi V.; Barreto G.E.; Sahebkar A. (Frontiers Media S.A., 2018)
ArticleCastro-Santos P.; Moro-García M.A.; Marcos-Fernández R.; Alonso-Arias R.; Díaz-Peña R. (SAGE Publications Ltd, 2017)
Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease (2020) Díaz-Peña R.; Vidal-Castiñeira J.R.; Moro-García M.A.; Alonso-Arias R.; Castro-Santos P. (Elsevier Inc., 2016)